Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR
Autor: | Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Frühwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I., Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F.H., Theissen, J., Volland, R., Hero, B., Simon, T. |
---|---|
Zdroj: | In Annals of Oncology March 2020 31(3):422-429 |
Databáze: | ScienceDirect |
Externí odkaz: |